Azithromycin in patients with COVID-19: Friend or foe?
- PMID: 33007473
- PMCID: PMC7524443
- DOI: 10.1016/j.cmi.2020.09.047
Azithromycin in patients with COVID-19: Friend or foe?
Comment on
-
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26. Clin Microbiol Infect. 2021. PMID: 32860962 Free PMC article.
References
-
- Fiolet T., Guihur A., Rebeaud M.E., Mulot M., Peiffer-Smadja N., Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Microbiol. 2020 doi: 10.1016/j.cmi.2020.08.022. - DOI - PMC - PubMed
-
- Milberg P., Eckardt L., Bruns H.J., Biertz J., Ramtin S., Reinsch N. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. J Pharmacol Exp Ther. 2002;303:218–225. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
